These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
656 related articles for article (PubMed ID: 19171136)
21. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163 [TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor stimulates Rac activation through Src and phosphatidylinositol 3-kinase to promote colonic epithelial cell migration. Dise RS; Frey MR; Whitehead RH; Polk DB Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G276-85. PubMed ID: 17991704 [TBL] [Abstract][Full Text] [Related]
23. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Masuda M; Suzui M; Weinstein IB Clin Cancer Res; 2001 Dec; 7(12):4220-9. PubMed ID: 11751523 [TBL] [Abstract][Full Text] [Related]
24. Novel D-ring analog of epigallocatechin-3-gallate inhibits tumor growth and VEGF expression in breast carcinoma cells. Waleh NS; Chao WR; Bensari A; Zaveri NT Anticancer Res; 2005; 25(1A):397-402. PubMed ID: 15816564 [TBL] [Abstract][Full Text] [Related]
25. Green tea (-)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met. Koh YW; Choi EC; Kang SU; Hwang HS; Lee MH; Pyun J; Park R; Lee Y; Kim CH J Nutr Biochem; 2011 Nov; 22(11):1074-83. PubMed ID: 21292466 [TBL] [Abstract][Full Text] [Related]
26. The Survivin-mediated radioresistant phenotype of glioblastomas is regulated by RhoA and inhibited by the green tea polyphenol (-)-epigallocatechin-3-gallate. McLaughlin N; Annabi B; Bouzeghrane M; Temme A; Bahary JP; Moumdjian R; Béliveau R Brain Res; 2006 Feb; 1071(1):1-9. PubMed ID: 16412397 [TBL] [Abstract][Full Text] [Related]
27. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration. Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695 [TBL] [Abstract][Full Text] [Related]
28. Green tea polyphenol-induced epidermal keratinocyte differentiation is associated with coordinated expression of p57/KIP2 and caspase 14. Hsu S; Yamamoto T; Borke J; Walsh DS; Singh B; Rao S; Takaaki K; Nah-Do N; Lapp C; Lapp D; Foster E; Bollag WB; Lewis J; Wataha J; Osaki T; Schuster G J Pharmacol Exp Ther; 2005 Mar; 312(3):884-90. PubMed ID: 15537824 [TBL] [Abstract][Full Text] [Related]
29. Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator. Ho YC; Yang SF; Peng CY; Chou MY; Chang YC J Oral Pathol Med; 2007 Nov; 36(10):588-93. PubMed ID: 17944751 [TBL] [Abstract][Full Text] [Related]
30. Modulation of NRF2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice. Zhang ZM; Yang XY; Yuan JH; Sun ZY; Li YQ Chin Med J (Engl); 2009 Jul; 122(14):1660-5. PubMed ID: 19719968 [TBL] [Abstract][Full Text] [Related]
31. The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma. Liu X; Zhang DY; Zhang W; Zhao X; Yuan C; Ye F Nutr Cancer; 2011; 63(3):466-75. PubMed ID: 21391127 [TBL] [Abstract][Full Text] [Related]
32. Epigallocatechin gallate dose-dependently induces apoptosis or necrosis in human MCF-7 cells. Hsuuw YD; Chan WH Ann N Y Acad Sci; 2007 Jan; 1095():428-40. PubMed ID: 17404055 [TBL] [Abstract][Full Text] [Related]
33. The phyto-chemical (-)-epigallocatechin gallate suppresses gene expression of epidermal growth factor receptor in rat hepatic stellate cells in vitro by reducing the activity of Egr-1. Fu Y; Chen A Biochem Pharmacol; 2006 Jul; 72(2):227-38. PubMed ID: 16750517 [TBL] [Abstract][Full Text] [Related]
34. Inhibitory effects of epigallocatechin-3-O-gallate on serum-stimulated rat aortic smooth muscle cells via nuclear factor-kappaB down-modulation. Han DW; Lim HR; Baek HS; Lee MH; Lee SJ; Hyon SH; Park JC Biochem Biophys Res Commun; 2006 Jun; 345(1):148-55. PubMed ID: 16677605 [TBL] [Abstract][Full Text] [Related]
35. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Siddiqui IA; Malik A; Adhami VM; Asim M; Hafeez BB; Sarfaraz S; Mukhtar H Oncogene; 2008 Mar; 27(14):2055-63. PubMed ID: 17998943 [TBL] [Abstract][Full Text] [Related]
36. Microarray-assisted pathway analysis identifies mitogen-activated protein kinase signaling as a mediator of resistance to the green tea polyphenol epigallocatechin 3-gallate in her-2/neu-overexpressing breast cancer cells. Guo S; Lu J; Subramanian A; Sonenshein GE Cancer Res; 2006 May; 66(10):5322-9. PubMed ID: 16707458 [TBL] [Abstract][Full Text] [Related]
37. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. Shimizu M; Deguchi A; Hara Y; Moriwaki H; Weinstein IB Biochem Biophys Res Commun; 2005 Sep; 334(3):947-53. PubMed ID: 16053920 [TBL] [Abstract][Full Text] [Related]
38. Ephrin-B3 ligand promotes glioma invasion through activation of Rac1. Nakada M; Drake KL; Nakada S; Niska JA; Berens ME Cancer Res; 2006 Sep; 66(17):8492-500. PubMed ID: 16951161 [TBL] [Abstract][Full Text] [Related]
39. Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion. Cheng XW; Kuzuya M; Nakamura K; Liu Z; Di Q; Hasegawa J; Iwata M; Murohara T; Yokota M; Iguchi A Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1864-70. PubMed ID: 16051878 [TBL] [Abstract][Full Text] [Related]
40. Investigations of the cytotoxicity of epigallocatechin-3-gallate against PC-3 cells in the presence of Cd2+ in vitro. Zhang LC; Yu HN; Sun SL; Yang JG; He GQ; Ruan H; Shen SR Toxicol In Vitro; 2008 Jun; 22(4):953-60. PubMed ID: 18359184 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]